Isomorphic Labs
Isomorphic Labs is a subsidiary of Alphabet Inc. created in November 2021. Its CEO is Demis Hassabis, who also leads Alphabet subsidiary DeepMind. The company aims to use artificial intelligence for drug discovery.[1][2][3]
References
- Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Archived from the original on November 5, 2021. Retrieved November 9, 2021.
- Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup". CNET.
- Coldeway, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch.
External links
| Subsidiaries |
|  | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| People |
| ||||||||||||||
| |||||||||||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.